Insider Transactions in Q2 2025 at Synaptogenix, Inc. (SNPX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Alan J Tuchman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,726
-30.63%
|
$12,082
$7.85 P/Share
|
|
Jun 30
2025
|
Alan J Tuchman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,315
+43.37%
|
-
|
|
Jun 30
2025
|
Bruce Bernstein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,863
-38.29%
|
$69,041
$7.85 P/Share
|
|
Jun 30
2025
|
Bruce Bernstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,657
+48.91%
|
-
|
|
Jun 30
2025
|
Jonathan Schechter Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,630
-38.08%
|
$60,410
$7.85 P/Share
|
|
Jun 30
2025
|
Jonathan Schechter Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,575
+48.77%
|
-
|
|
Jun 30
2025
|
Joshua Silverman Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
16,768
-38.59%
|
$117,376
$7.85 P/Share
|
|
Jun 30
2025
|
Joshua Silverman Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
41,919
+49.1%
|
-
|
|
Jun 30
2025
|
Robert Weinstein Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,164
-36.83%
|
$43,148
$7.85 P/Share
|
|
Jun 30
2025
|
Robert Weinstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,410
+47.93%
|
-
|
|
Jun 30
2025
|
William S. Singer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,164
-36.84%
|
$43,148
$7.85 P/Share
|
|
Jun 30
2025
|
William S. Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,410
+47.95%
|
-
|